Receptor profiling and endocrine interactions of tibolone

Area of Science:

• Endocrinology
• Pharmacology
• Molecular Biology

Background:

• Tibolone is a synthetic steroid used in hormone replacement therapy.
• Its pharmacological effects are attributed to its metabolites, but their specific receptor interactions require clarification.

Purpose of the Study:

• To characterize the receptor binding and in vivo activity of tibolone and its primary metabolites.
• To compare these activities with structurally related compounds.

Main Methods:

• Receptor binding assays for progesterone (PR), estrogen (ERalpha, ERbeta), and androgen (AR) receptors.
• In vivo studies in rabbits and ovariectomized rats to assess progestagenic and estrogenic effects.
• Comparison of tibolone and its metabolites (Delta(4)-isomer, 3alpha/beta-hydroxytibolone) with known modulators.

Main Results:

• The Delta(4)-isomer strongly binds and activates PR, mediating tibolone's progestagenic and androgenic activity.
• 3-Hydroxytibolones are potent ER binders and activators, responsible for tibolone's estrogenic effects.
• Estrogenic activity of 3-hydroxytibolones masked progestagenic effects in rabbit endometrium.

Conclusions:

• Tibolone's progestagenic and androgenic activities are mediated by its Delta(4)-isomer metabolite.
• Tibolone's estrogenic activity is mediated by its 3-hydroxytibolone metabolites.
• Understanding these metabolite-specific actions is crucial for tibolone's therapeutic application.